CD274 and colorectal carcinoma: In summary, although gefitinib may affect PD-L1 expression, NDAT inhibited PI3K expression and PD-L1 accumulation to inhibit cell proliferation in gefitinib-resistant CRC proliferation in vitro and in vivo.